M. Yilmaz Et Al. , "Comments on "Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study".," Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners , vol.25, pp.2060-2062, 2019
Yilmaz, M. Et Al. 2019. Comments on "Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study".. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners , vol.25 , 2060-2062.
Yilmaz, M., Elmali, A., & Yazici, G., (2019). Comments on "Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study".. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners , vol.25, 2060-2062.
Yilmaz, MT, AYŞENUR ELMALI, And GÖZDE YAZICI. "Comments on "Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study".," Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners , vol.25, 2060-2062, 2019
Yilmaz, MT Et Al. "Comments on "Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study".." Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners , vol.25, pp.2060-2062, 2019
Yilmaz, M. Elmali, A. And Yazici, G. (2019) . "Comments on "Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study".." Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners , vol.25, pp.2060-2062.
@article{article, author={MT Yilmaz Et Al. }, title={Comments on "Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study".}, journal={Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners}, year=2019, pages={2060-2062} }